Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

323.86
Delayed Data
As of Feb 23
 +8.04 / +2.55%
Today’s Change
313.53
Today|||52-Week Range
543.55
-13.86%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 440.00, with a high estimate of 568.00 and a low estimate of 387.00. The median estimate represents a +35.86% increase from the last price of 323.86.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$4.47
Sales
$1.5B
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.13%
 
 
 
 
 
 
Growthannually 12.53%
 
 
 
 
 
 

Sales

Growthquarterly -0.07%
 
 
 
 
 
 
Growthannually 8.75%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.